Tamsulosin Hydrochloride Capsule
Product Images NDC 72162-2509

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 72162-2509). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721622509)

Label for Tamsulosin Hydrochloride Capsules USP 0.4 mg, oral dosage form, in a package of 100 capsules. The label shows the NDC 72162-2509-1 and indicates the product is Rx only. It is relabeled by Bryant Ranch Prepack, Inc., Burbank, CA, and manufactured by Aurobindo Pharma Limited. Storage instructions and QR codes for package insert and prescribing information are also displayed.*

FDA Label Image

Figure 1 Mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-dose Administration Of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted And Fed Conditions (n=8) (Tamsulosin Fig1)

A line graph depicting mean plasma concentrations of Tamsulosin Hydrochloride (0.4 mg capsules) over time up to 36 hours, comparing fasted and fed conditions in 8 subjects. The y-axis shows plasma concentration in ng/mL, while the x-axis represents time in hours. The graph includes two lines: a dashed line for fasted and a solid line for fed conditions, showing concentration peaks and decline patterns.*

FDA Label Image

Figure 2a Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 1 (Tamsulosin Fig2)

A line graph titled 'Figure 2A Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 1' showing mean change over treatment duration in weeks. The x-axis represents weeks of treatment (0 to 13) and the y-axis represents mean change. Three treatment groups are shown: 0.8 mg, 0.4 mg, and placebo. Mean symptom scores decrease over time across groups, with the 0.8 mg group showing the greatest reduction, followed by 0.4 mg, and placebo with the least. Data points include sample sizes at each time point.*

FDA Label Image

Figure 2b Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 2 (Tamsulosin Fig3)

A line graph titled 'Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 2' showing mean change on the y-axis and duration of treatment in weeks on the x-axis. The graph compares three treatments: 0.8 mg, 0.4 mg of Tamsulosin Hydrochloride, and placebo. The 0.8 mg and 0.4 mg treatments show a greater reduction in symptom score over time compared to placebo.*

FDA Label Image

Figure 3a Mean Increase In Peak Urine Flow Rate (ml/sec) Study 1 (Tamsulosin Fig4)

A line graph titled 'Figure 3A Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 1' showing mean changes in peak urine flow rate over a duration of treatment in weeks. The graph compares three groups: 0.8 mg treatment (circles), 0.4 mg treatment (triangles), and placebo (squares). The y-axis represents mean change in mL/sec, and the x-axis represents treatment duration in weeks from baseline (B) to last observed carried forward (LOCF).*

FDA Label Image

Figure 3b Mean Increase In Peak Urine Flow Rate (ml/sec) Study 2 (Tamsulosin Fig5)

A line graph titled 'Figure 3B Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 2' showing mean change in mL/sec over treatment duration in weeks. Three treatments—0.8 mg, 0.4 mg, and placebo—are compared, with 0.8 mg and 0.4 mg showing higher mean increases in peak urine flow rate than placebo over time.*

FDA Label Image

Chemical Structure (Tamsulosin Str)

Chemical structure of Tamsulosin Hydrochloride, showing the molecular arrangement including aromatic rings, methoxy, sulfonamide groups, and hydrochloride salt representation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.